ERIN GREER: Open Payments
NPI 1962743088 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 42 payments from 12 companies in 2025. Trend: 2023 $1,438 · 2024 $651 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 12 | $188 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $97 |
| PFIZER INC. | 3 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Novartis Pharmaceuticals Corporation | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Kestra Medical Technology Services, Inc. | 1 | $36 |
| Daiichi Sankyo Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $17 |
Products named: ELIQUIS, LifeVest, FARXIGA, LEQVIO, VYNDAQEL, CAMZYOS, Kerendia, JARDIANCE.
Industry payments across KY — which companies pay providers there.
